MedTrace Logo

Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial

NCT00328822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2008-03-18

No results posted yet for this study

Summary

Primary insomnia patients will sleep with Quetiapine not better than without Quetiapine

Conditions

  • Primary Insomnia

Interventions

DRUG

Quetiapine

DRUG

placebo

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Kanida Tassniyom, MD · Department of Psychiatry, Faculty of Medicine, Khon Kaen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Completion
2007-08-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00328822 on ClinicalTrials.gov